Table 3.
Summary of the Number of OXPHOS Genes that Are Differentially Expressed between Control and Treatment Conditions by Genome Type and by Group
| Complex | Genome | LJ | K | F1 |
|---|---|---|---|---|
| CI | Nuclear | 6 | 3 | 4 |
| CI | Mitochondrial | 2 | 0 | 0 |
| CII | Nuclear | 0 | 0 | 0 |
| CII | Mitochondrial | N/A | N/A | N/A |
| CIII | Nuclear | 5 | 3 | 4 |
| CIII | Mitochondrial | 0 | 0 | 0 |
| CIV | Nuclear | 1 | 0 | 0 |
| CIV | Mitochondrial | 1 | 0 | 0 |
| CV | Nuclear | 2 | 1 | 2 |
| CV | Mitochondrial | 2 | 0 | 0 |
| % Nuclear | 20.3 | 10.1 | 14.5 | |
| % Mitochondrial | 38.5 | 0.0 | 0.0 |
Note.—Each cell refers to the number of statistically significant differentially expressed genes out of 80 targets examined.